Millennium’s CTO Michael Pavia says the company employs its homemade DNA chips to streamline just about every area of the drug discovery process.
By Peter Gwynne
Michael Pavia has a mission. He wants to cut the cost of bringing new drugs to market by 50 percent. As chief technology officer of Millennium Pharmaceuticals, he is well placed to do so.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
